US5916891A
(en)
|
1992-01-13 |
1999-06-29 |
Smithkline Beecham Corporation |
Pyrimidinyl imidazoles
|
US6046208A
(en)
*
|
1996-01-11 |
2000-04-04 |
Smithkline Beecham Corporation |
Substituted imidazole compounds
|
BR9710352A
(pt)
|
1996-07-11 |
1999-08-17 |
Pfizer |
Compostos piridilpirrole
|
WO1998022457A1
(fr)
|
1996-11-19 |
1998-05-28 |
Amgen Inc. |
Agents anti-inflammatoires a base de pyrrole condense a substitution aryle et heteroaryle
|
US6410729B1
(en)
|
1996-12-05 |
2002-06-25 |
Amgen Inc. |
Substituted pyrimidine compounds and methods of use
|
EP1314732A3
(fr)
*
|
1996-12-05 |
2004-01-02 |
Amgen Inc. |
Composés de pyrimidine substitués et leur utilisation
|
CN1328277C
(zh)
*
|
1996-12-05 |
2007-07-25 |
安姆根有限公司 |
取代的嘧啶酮和吡啶酮化合物和它们的应用
|
AR038955A1
(es)
*
|
1996-12-05 |
2005-02-02 |
Amgen Inc |
Compuestos de pirimidinona y piridona sustituidos y metodos para su uso
|
US6096753A
(en)
|
1996-12-05 |
2000-08-01 |
Amgen Inc. |
Substituted pyrimidinone and pyridone compounds and methods of use
|
BR9810007B1
(pt)
|
1997-06-12 |
2010-04-06 |
|
compostos, e, derivados da resina de merrifield.
|
US6613942B1
(en)
|
1997-07-01 |
2003-09-02 |
Novo Nordisk A/S |
Glucagon antagonists/inverse agonists
|
WO1999001423A1
(fr)
*
|
1997-07-01 |
1999-01-14 |
Novo Nordisk A/S |
Antagonistes/agonistes inverses du glucagon
|
US7301021B2
(en)
|
1997-07-02 |
2007-11-27 |
Smithkline Beecham Corporation |
Substituted imidazole compounds
|
WO1999023091A1
(fr)
*
|
1997-11-03 |
1999-05-14 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Composes heterocycliques aromatiques convenant comme anti-inflammatoires
|
EP1473292A1
(fr)
*
|
1997-11-03 |
2004-11-03 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Composes heterocycliques aromatiques convenant en tant qu'agents anti-inflammatoires
|
US6022884A
(en)
|
1997-11-07 |
2000-02-08 |
Amgen Inc. |
Substituted pyridine compounds and methods of use
|
EP1037639A4
(fr)
|
1997-12-19 |
2002-04-17 |
Smithkline Beecham Corp |
.0mposes d'imidazole heteroaryle substitues, leurs compositions et usages pharmaceutiques
|
US6174901B1
(en)
|
1998-12-18 |
2001-01-16 |
Amgen Inc. |
Substituted pyridine and pyridazine compounds and methods of use
|
ATE295166T1
(de)
*
|
1998-01-14 |
2005-05-15 |
Nippon Shinyaku Co Ltd |
Aktivatoren der kalium-kanäle
|
DE69904318D1
(de)
*
|
1998-05-12 |
2003-01-16 |
Wyeth Corp |
Zur behandlung von insulin-resistenz und hyperglycemie geeignete biphenyl-oxo-essigsäuren
|
US6232322B1
(en)
|
1998-05-12 |
2001-05-15 |
American Home Products Corporation |
Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
|
US6858617B2
(en)
|
1998-05-26 |
2005-02-22 |
Smithkline Beecham Corporation |
Substituted imidazole compounds
|
JP2002526388A
(ja)
|
1998-10-07 |
2002-08-20 |
スミスクライン・ビーチャム・コーポレイション |
発作を管理するための新規な処置
|
DE19847823A1
(de)
*
|
1998-10-16 |
2000-04-20 |
Aventis Pharma Gmbh |
Substituierte Thiadiazolsulfonamide
|
EP1126852B1
(fr)
|
1998-11-04 |
2004-01-21 |
SmithKline Beecham Corporation |
Pyrazines substitues pyridin-4-yle ou pyrimidin-4-yle
|
UA73492C2
(en)
|
1999-01-19 |
2005-08-15 |
|
Aromatic heterocyclic compounds as antiinflammatory agents
|
WO2000055152A1
(fr)
|
1999-03-12 |
2000-09-21 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Composes aromatiques heterocycliques utilises en tant qu'agents anti-inflammatoires
|
WO2000066124A1
(fr)
*
|
1999-04-28 |
2000-11-09 |
Sankyo Company, Limited |
Agents preventifs ou inhibiteurs destines a une hepatopathie
|
US6310081B1
(en)
|
1999-05-10 |
2001-10-30 |
American Home Products Corporation |
Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
|
WO2000069847A1
(fr)
*
|
1999-05-14 |
2000-11-23 |
Ortho-Mcneil Pharmaceutical, Inc. |
3-pyridyle-4-arylpyrroles substitues et methodes prophylactiques et therapeutiques associees
|
US6503949B1
(en)
|
1999-05-17 |
2003-01-07 |
Noro Nordisk A/S |
Glucagon antagonists/inverse agonists
|
MXPA02000314A
(es)
|
1999-07-09 |
2004-06-22 |
Boehringer Ingelheim Pharma |
Proceso novedoso para la sintesis de compuestos de urea substituidos con heteroarilo.
|
US7122666B2
(en)
|
1999-07-21 |
2006-10-17 |
Sankyo Company, Limited |
Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses
|
EP1216241B1
(fr)
*
|
1999-09-14 |
2005-12-07 |
Merck Frosst Canada & Co. |
Acides carboxyliques et acylsulfonamides, compositions contenant de tels composes et methodes de traitement
|
US6900043B1
(en)
|
1999-09-21 |
2005-05-31 |
Amgen Inc. |
Phosphatases which activate map kinase pathways
|
AU1053501A
(en)
*
|
1999-11-02 |
2001-05-14 |
Ajinomoto Co., Inc. |
Polyazanaphthalene compound and medicinal use thereof
|
US6492393B1
(en)
|
1999-11-16 |
2002-12-10 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Compounds useful as anti-inflammatory agents
|
EP1233950B1
(fr)
|
1999-11-23 |
2005-10-05 |
Smithkline Beecham Corporation |
3,4-dihydro-(1h)quinazolin-2-ones comme inhibiteurs de csbp/p38 kinase
|
US6759410B1
(en)
|
1999-11-23 |
2004-07-06 |
Smithline Beecham Corporation |
3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors
|
JP2003514900A
(ja)
|
1999-11-23 |
2003-04-22 |
スミスクライン・ビーチャム・コーポレイション |
CSBP/p38キナーゼ阻害剤としての3,4−ジヒドロ−(1H)−キナゾリン−2−オン化合物
|
US6525046B1
(en)
|
2000-01-18 |
2003-02-25 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aromatic heterocyclic compounds as antiinflammatory agents
|
CA2673615C
(fr)
|
2000-01-21 |
2013-07-16 |
Novartis Ag |
Combinaisons comprenant des inhibiteurs de la dipeptidylpeptidase- iv et des agents antidiabetiques
|
US6608052B2
(en)
|
2000-02-16 |
2003-08-19 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Compounds useful as anti-inflammatory agents
|
US7235551B2
(en)
|
2000-03-02 |
2007-06-26 |
Smithkline Beecham Corporation |
1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
|
US6562807B2
(en)
|
2000-06-23 |
2003-05-13 |
Novo Nordisk A/S |
Glucagon antagonists/inverse agonists
|
US6706744B2
(en)
|
2000-11-17 |
2004-03-16 |
Novo Nordisk A/S |
Glucagon antagonists/inverse agonists
|
WO2002040445A1
(fr)
|
2000-11-17 |
2002-05-23 |
Novo Nordisk A/S |
Agonistes de glucagon/antagonistes inverses
|
US6821960B2
(en)
|
2000-11-17 |
2004-11-23 |
Noyo Nordisk Pharmaceuticals, Inc. |
Glucagon antagonists/inverse agonists
|
BR0206533A
(pt)
*
|
2001-01-18 |
2003-12-16 |
Sankyo Co |
Composto, composição farmacêutica, e, uso de um composto
|
WO2002057255A1
(fr)
*
|
2001-01-22 |
2002-07-25 |
Sankyo Company, Limited |
Derives du pyrrole substitues en 4 ou 5
|
MY130778A
(en)
|
2001-02-09 |
2007-07-31 |
Vertex Pharma |
Heterocyclic inhibitiors of erk2 and uses thereof
|
WO2002092576A1
(fr)
|
2001-05-16 |
2002-11-21 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Derives de diaryluree utilisables en tant qu'agents anti-inflammatoires
|
MXPA03010724A
(es)
|
2001-05-25 |
2004-03-02 |
Boehringer Ingelheim Pharma |
Compuestos de carbamato y oxamida como inhibidores de la produccion de citocina.
|
AU2002317377A1
(en)
*
|
2001-07-20 |
2003-03-03 |
Cancer Research Technology Limited |
Biphenyl apurinic/apyrimidinic site endonuclease inhibitors to treat cancer
|
KR100896667B1
(ko)
*
|
2001-08-28 |
2009-05-14 |
레오 파마 에이/에스 |
신규한 아미노벤조페논 및 이를 포함하는 약제학적 조성물
|
WO2003022832A1
(fr)
*
|
2001-09-05 |
2003-03-20 |
Smithkline Beecham P.L.C. |
Pyridylfurans et pyrroles inhibiteurs de la kinase raf
|
US6921762B2
(en)
|
2001-11-16 |
2005-07-26 |
Amgen Inc. |
Substituted indolizine-like compounds and methods of use
|
US6881746B2
(en)
|
2001-12-03 |
2005-04-19 |
Novo Nordick A/S |
Glucagon antagonists/inverse agonists
|
CA2473634C
(fr)
|
2002-02-25 |
2011-11-29 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Composes de cycloalkyle uree benzofusionnes a disubstitution en position 1,4 utiles dans le traitement de maladies mediees par la cytokine
|
AU2003245989A1
(en)
|
2002-07-09 |
2004-01-23 |
Boehringer Ingelheim Pharma Gmbh And Co. Kg |
Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases
|
MXPA05003264A
(es)
*
|
2002-09-27 |
2005-10-18 |
Johnson & Johnson |
Pirroles 3,4-disustituidos y su uso en el tratamiento de enfermedades inflamatorias.
|
US7196106B2
(en)
|
2002-11-05 |
2007-03-27 |
Merck & Co., Inc |
Cyanothiophene derivatives, compositions containing such compounds and methods of use
|
AU2004210127B2
(en)
|
2003-01-27 |
2009-10-01 |
Merck Sharp & Dohme Corp. |
Substituted pyrazoles, compositions containing such compounds and methods of use
|
CA2547785A1
(fr)
|
2003-12-19 |
2005-07-21 |
Merck & Co., Inc. |
Guanidines cycliques, compositions contenant de tels composes et procedes d'utilisation
|
ES2306165T3
(es)
|
2004-06-04 |
2008-11-01 |
MERCK & CO., INC. |
Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso.
|
US7625938B2
(en)
|
2004-07-22 |
2009-12-01 |
Merck & Co., Inc. |
Substituted pyrazoles, compositions containing such compounds and methods of use
|
US20060035893A1
(en)
|
2004-08-07 |
2006-02-16 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
|
PE20060777A1
(es)
|
2004-12-24 |
2006-10-06 |
Boehringer Ingelheim Int |
Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
|
US7759337B2
(en)
|
2005-03-03 |
2010-07-20 |
Amgen Inc. |
Phthalazine compounds and methods of use
|
AU2006227435A1
(en)
|
2005-03-21 |
2006-09-28 |
Merck Sharp & Dohme Corp. |
Substituted aryl and heteroaryl derivatives
|
JP2008534593A
(ja)
|
2005-03-30 |
2008-08-28 |
メルク エンド カムパニー インコーポレーテッド |
グルカゴン受容体アンタゴニスト化合物、そのような化合物を含む組成物、及びその使用方法
|
JP2009502923A
(ja)
|
2005-07-26 |
2009-01-29 |
メルク エンド カムパニー インコーポレーテッド |
置換ピラゾールを合成するための方法
|
BRPI0616077B8
(pt)
|
2005-09-14 |
2021-05-25 |
Takeda Pharmaceuticals Co |
composição farmacêutica formulada em uma dose única, kit, artigo de manufatura, uso da composição farmacêutica e uso de um ou mais compostos antidiabéticos
|
EP1928827B1
(fr)
|
2005-09-27 |
2012-08-22 |
Myriad Genetics, Inc. |
Derives de pyrroles utilises en tant qu'agents therapeutiques
|
TW200745031A
(en)
|
2005-10-13 |
2007-12-16 |
Merck & Co Inc |
Acyl indoles, compositions containing such compounds and methods of use
|
AU2007229850A1
(en)
|
2006-03-23 |
2007-10-04 |
Merck & Co., Inc. |
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
|
EP2038289A2
(fr)
|
2006-04-21 |
2009-03-25 |
Amgen Inc. |
Composés de thiéno-[2,3-d]pyrimidine et de thiénopyridazine et procédés d'utilisation de ceux-ci
|
AU2007254329A1
(en)
|
2006-05-16 |
2007-11-29 |
Merck & Co., Inc. |
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
|
AU2007275696B2
(en)
|
2006-07-17 |
2011-11-10 |
Amgen Inc. |
Quinazoline and pyridopyrimidine derivatives as p38 kinase inhibitors
|
WO2008030466A1
(fr)
|
2006-09-05 |
2008-03-13 |
Amgen Inc. |
Composés de phtalazine, d'aza-phtalazine et de diaza-phtalazine et procédés d'utilisation
|
US20100105664A1
(en)
|
2006-09-21 |
2010-04-29 |
Richard Heng |
Organic compounds
|
TW200821284A
(en)
|
2006-10-03 |
2008-05-16 |
Merck & Co Inc |
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
|
CA2665195C
(fr)
|
2006-10-11 |
2011-08-09 |
Amgen Inc. |
Composes d'imidazo- et de triazolo-pyridine et leurs procedes d'utilisation
|
PL2116530T3
(pl)
*
|
2007-02-26 |
2013-03-29 |
Santen Pharmaceutical Co Ltd |
Nowa pochodna pirolu zawierająca jako podstawniki grupę ureidową i grupę aminokarbonylową
|
EP1992344A1
(fr)
|
2007-05-18 |
2008-11-19 |
Institut Curie |
P38 alpha comme cible therapeutique pour les maladies associées á une mutation de FGFR3
|
US8314131B2
(en)
|
2007-09-21 |
2012-11-20 |
Amgen Inc. |
Triazole fused heteroaryl compounds and methods of use thereof
|
WO2010025201A1
(fr)
|
2008-08-29 |
2010-03-04 |
Amgen Inc. |
Composés pyridazino-pyridinone utilisés pour le traitement de maladies médiées par une protéine kinase
|
WO2010025202A1
(fr)
|
2008-08-29 |
2010-03-04 |
Amgen Inc. |
Composés pyrido[3,2-d]pyridazine-2(1h)-one en tant que modulateurs de p38 et leurs procédés d'utilisation
|
WO2010042649A2
(fr)
|
2008-10-10 |
2010-04-15 |
Amgen Inc. |
Composés de phtalazine en tant que modulateurs de map kinase p38 et procédés pour les utiliser
|
US8772481B2
(en)
|
2008-10-10 |
2014-07-08 |
Amgen Inc. |
Aza- and diaza-phthalazine compounds as P38 map kinase modulators and methods of use thereof
|
WO2011041293A1
(fr)
|
2009-09-30 |
2011-04-07 |
Takeda Pharmaceutical Company Limited |
Dérivés pyrazolo [1, 5a] pyrimidines comme inhibiteurs de kinase 1 régulatrice de signal d'apoptose
|
DK2531501T3
(en)
|
2010-02-03 |
2014-02-24 |
Takeda Pharmaceutical |
APOPTOSESIGNALREGULERENDE KINASE 1 inhibitors
|
BR112013016033A2
(pt)
|
2010-12-23 |
2018-06-05 |
Pfizer |
moduladores do receptor de glucagon
|
EA023517B1
(ru)
|
2011-02-08 |
2016-06-30 |
Пфайзер Инк. |
Модуляторы глюкагонового рецептора
|
BR112014000288A2
(pt)
|
2011-07-22 |
2017-01-10 |
Pfizer |
moduladores do receptor de glucagon de quinolinila
|
US9649294B2
(en)
|
2013-11-04 |
2017-05-16 |
Merck Sharp & Dohme Corp. |
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
|
IT201800003680A1
(it)
*
|
2018-03-16 |
2019-09-16 |
Univ Degli Studi Di Siena |
Composti antivirali e usi di essi
|